Phase I clinical trial: 2DG [2-deoxy-D-glucose] + stereotactic radiosurgery (SRS) protocol for treatment of intracranial metastases

Trial Profile

Phase I clinical trial: 2DG [2-deoxy-D-glucose] + stereotactic radiosurgery (SRS) protocol for treatment of intracranial metastases

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 16 Apr 2015

At a glance

  • Drugs 2-deoxy-D-glucose (Primary)
  • Indications Cancer metastases
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Dec 2009 Actual end date (June 2008) added as reported by ClinicalTrials.gov.
    • 29 Dec 2009 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 09 Jun 2008 Actual initiation date Oct 2005 added as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top